Riskpilot← Back to searchSign inGet full accessBIOTRONIK ApS
APSActiveCVR 26933501Hovedgaden 55DWholesale of pharmaceutical and medical goods · NACE 4646Est. 20037 employees
Revenue 2024
DKK 9,4M
-15% vs 2023
EBITDA margin
22.7%
-19% vs 2023
Equity ratio
34.5%
Financial strength
Net profit 2024
DKK 1,1M
-26% vs 2023
| Revenue | DKK 9,4M | -15% |
| EBITDA | DKK 2,1M | -19% |
| Net profit | DKK 1,1M | -26% |
| Total assets | DKK 16,2M | -29% |
| Equity | DKK 5,6M | -32% |
| Employees | 7 | — |
Legal name
BIOTRONIK ApS
CVR number
26933501
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. januar 2003
Share capital
DKK 135.000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør eller to direktører i forening.
Company purpose
Selskabets formål er markedsføring og salg af produkter for behandling af hjertekar og perifere karsygdomme, samt, direkte eller indirekte, at drive anden virksomhed, der efter direktio-nens skøn er forbunden dermed.
Address
Hovedgaden 55D
Phone
+4545860886
Email
biotronik.danmark@biotronik.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.497 | 11.085 | 7.457 | 13.554 | 14.389 | 17.902 | 10.285 | 9.847 | 9.950 | 9.103 | 9.423 | 11.048 | 9.429 |
| Staff expenses | -8.460 | -7.923 | -8.305 | -8.880 | -7.702 | -8.842 | -8.713 | -7.526 | -7.659 | -7.105 | -7.575 | -8.329 | -7.288 |
| EBITDA | 1.037 | 3.161 | -848 | 4.674 | 6.687 | 9.060 | 1.572 | 2.321 | 2.291 | 1.866 | 1.840 | 2.628 | 2.141 |
| Depreciation & amort. | -283 | -303 | -291 | -315 | -279 | -231 | -119 | -854 | -867 | -655 | -564 | -620 | -634 |
| EBIT | 754 | 2.858 | -1.139 | 4.360 | 6.408 | 8.829 | 1.452 | 1.467 | 1.424 | 1.212 | 1.276 | 2.008 | 1.507 |
| Net financials | -70 | -43 | -165 | -211 | -164 | -452 | -302 | -133 | -193 | -168 | -149 | -41 | -58 |
| Profit before tax | 684 | 2.815 | -1.304 | 4.148 | 6.244 | 8.377 | 1.150 | 1.334 | 1.230 | 1.044 | 1.127 | 1.967 | 1.449 |
| Tax | 214 | 862 | -317 | 1.009 | 1.386 | 1.852 | 263 | 358 | 271 | 236 | 262 | 466 | 331 |
| Net profit | 471 | 1.953 | -987 | 3.139 | 4.858 | 6.525 | 887 | 977 | 959 | 808 | 864 | 1.501 | 1.117 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 24.936 | 26.258 | 22.194 | 18.792 | 33.446 | 36.421 | 33.551 | 36.254 | 28.271 | 29.437 | 24.551 | 22.881 | 16.223 |
| Equity | 8.446 | 10.399 | 9.412 | 12.551 | 17.409 | 23.934 | 24.819 | 25.796 | 16.755 | 17.563 | 10.427 | 8.196 | 5.593 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 338 | 0 | 275 | 455 | 275 | 366 |
| Short-term debt | 13.519 | 12.355 | 10.925 | 4.529 | 14.869 | 11.010 | 7.154 | 10.120 | 11.516 | 11.599 | 13.669 | 14.410 | 10.242 |
| Total debt | 13.519 | 12.355 | 10.925 | 4.529 | 14.869 | 11.010 | 7.154 | 10.458 | 11.516 | 11.874 | 14.123 | 14.685 | 10.608 |
EBITDA margin
22.7%
This company
15.8%
Market median
+44% vs market
20122024
Equity ratio
34.5%
This company
38.2%
Market median
+10% vs market
20122024
Return on equity
20.0%
This company
18.4%
Market median
+9% vs market
20122024
Net profit margin
11.8%
This company
8.1%
Market median
+46% vs market
20122024
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20122024
Debt / equity
1.90×
This company
0.62×
Market median
-206% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AH Chief Executive Officer | Chief Executive Officer | 2003 | — | — |
BJ Chief Executive Officer | Chief Executive Officer | 2011 | — | — |
NJ Management | Management | 2011 | — | — |
JR Management | Management | 2003 | — | — |
MR Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
BB Management | Management | 2003 | — | — |
Jd Management | Management | 2003 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2011 | — | — | |
| Board of Directors | 2003 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2004 | — | — | |
| Chairman | 2003 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2003 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOTRONIK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Annemette Heller | Chief Executive Officer | 0 companies |
| Bernhard Johannes Sembdner | Chief Executive Officer | 0 companies |
| Niels Jørn Madsen | Management | 0 companies |
| James Roger Apelberg | Management | 0 companies |
| Mario Roberto Belke | Chief Executive Officer | 0 companies |
| Birgitte Bødker Dyreborg | Management | 0 companies |
| Jacob de Boer | Management | 0 companies |
| Udo Tegtmeyer | Chairman | 0 companies |
| Peter Antonius de Jong | Board of Directors | 0 companies |
| Mario Roberto Belke | Board of Directors | 0 companies |
| Robert Nitsche | Board of Directors | 0 companies |
| Werner Braun | Board of Directors | 0 companies |
| Kim Madsen | Chairman | 0 companies |
| Dirk Lars Schmerl | Board of Directors | 0 companies |
| Kordt Griepenkerl | Board of Directors | 0 companies |